New Business Unit, Cytovis™, International Stem Cell (OTCBB: ISCO)
August 20th, 2010
No comments
ISCO.OB’s stem cell therapeutic programs focused on protective, transparent corneas (CytoCor™) in the front of the eye and the light-sensitive retinal tissue (CytoRet™) in the back of the eye will be formalized into a new business unit, Cytovis™. Read more…
Categories: Cytovis, Stem Cell Technology
